Ann Arbor, MI, United States of America

Xu Ran


 

Average Co-Inventor Count = 16.5

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovator Profile: Xu Ran**

Introduction

Xu Ran is a notable inventor based in Ann Arbor, Michigan, recognized for his contributions to the field of pharmaceutical sciences. With four patents to his name, he focuses on developing innovative therapeutic methods aimed at combating diseases such as cancer. His work has the potential to significantly impact treatment options in modern medicine.

Latest Patents

Xu Ran's recent patents include groundbreaking developments in BET bromodomain inhibitors. His first patent discusses inhibitors of BET bromodomains and the therapeutic applications thereof. These inhibitors show promising results in treating conditions where BET bromodomain inhibition is beneficial, especially various forms of cancer. Another key patent details the use of substituted 9H-pyrimido[4,5-b]indoles and 5H-pyrido[4,3-b]indoles. This patent provides insights into the pharmaceutical compositions and therapeutic uses of compounds identified by specific structural formulas, particularly emphasizing their efficacy in treating cancer by inhibiting BET bromodomains.

Career Highlights

Currently, Xu Ran is affiliated with the University of Michigan, contributing to its research and development projects. His work not only advances the scientific community's understanding of BET bromodomains but also embodies the application of cutting-edge research towards meaningful healthcare solutions.

Collaborations

Collaboration plays a pivotal role in Xu Ran's work, particularly with esteemed colleagues such as Shaomeng Wang and Yujun Zhao. Together, they contribute to a dynamic research environment that fosters innovation and the exploration of new therapeutic avenues.

Conclusion

Xu Ran's contributions to the field of medicine through his patents on BET bromodomain inhibitors highlight his status as an integral part of contemporary scientific research. His work not only provides new methods for treating critical health issues but also inspires future innovations in the pharmaceutical industry. As his research progresses, it is poised to open new doors for effective cancer treatments and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…